Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders

Detalles Bibliográficos
Autores principales: Ries, Markus, Lutz, Thomas, Lampert, Anette, Mountford, William, Mechler, Konstantin, Hoffmann, Georg F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715114/
https://www.ncbi.nlm.nih.gov/pubmed/27484192
http://dx.doi.org/10.1186/2194-7791-2-S1-A1
_version_ 1782410419259834368
author Ries, Markus
Lutz, Thomas
Lampert, Anette
Mountford, William
Mechler, Konstantin
Hoffmann, Georg F
author_facet Ries, Markus
Lutz, Thomas
Lampert, Anette
Mountford, William
Mechler, Konstantin
Hoffmann, Georg F
author_sort Ries, Markus
collection PubMed
description
format Online
Article
Text
id pubmed-4715114
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-47151142016-01-31 Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders Ries, Markus Lutz, Thomas Lampert, Anette Mountford, William Mechler, Konstantin Hoffmann, Georg F Mol Cell Pediatr Meeting Abstract Springer Berlin Heidelberg 2015-07-01 /pmc/articles/PMC4715114/ /pubmed/27484192 http://dx.doi.org/10.1186/2194-7791-2-S1-A1 Text en © Ries et al. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Ries, Markus
Lutz, Thomas
Lampert, Anette
Mountford, William
Mechler, Konstantin
Hoffmann, Georg F
Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title_full Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title_fullStr Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title_full_unstemmed Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title_short Novel orphan medicines and abandoned pathways - the US Orphan Drug Act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
title_sort novel orphan medicines and abandoned pathways - the us orphan drug act of 1983 and the impact on rare rheumatologic diseases and lysosomal storage disorders
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715114/
https://www.ncbi.nlm.nih.gov/pubmed/27484192
http://dx.doi.org/10.1186/2194-7791-2-S1-A1
work_keys_str_mv AT riesmarkus novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders
AT lutzthomas novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders
AT lampertanette novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders
AT mountfordwilliam novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders
AT mechlerkonstantin novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders
AT hoffmanngeorgf novelorphanmedicinesandabandonedpathwaystheusorphandrugactof1983andtheimpactonrarerheumatologicdiseasesandlysosomalstoragedisorders

Ejemplares similares